143 related articles for article (PubMed ID: 30086433)
1. Identifying novel therapeutic targets for diabetes through improved understanding of islet adhesion receptors.
Olaniru OE; Persaud SJ
Curr Opin Pharmacol; 2018 Dec; 43():27-33. PubMed ID: 30086433
[TBL] [Abstract][Full Text] [Related]
2. Editorial overview: Endocrine and metabolic diseases Druggable diabetes: identification of therapeutic opportunities.
Persaud SJ; Bowe JE
Curr Opin Pharmacol; 2018 Dec; 43():iii-v. PubMed ID: 30446351
[No Abstract] [Full Text] [Related]
3. An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans.
Amisten S; Salehi A; Rorsman P; Jones PM; Persaud SJ
Pharmacol Ther; 2013 Sep; 139(3):359-91. PubMed ID: 23694765
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of pancreatic PAX4-regulated pathways in treating diabetes mellitus.
Lorenzo PI; Cobo-Vuilleumier N; Gauthier BR
Curr Opin Pharmacol; 2018 Dec; 43():1-10. PubMed ID: 30048825
[TBL] [Abstract][Full Text] [Related]
5. Targeting protein misfolding to protect pancreatic beta-cells in type 2 diabetes.
Costes S
Curr Opin Pharmacol; 2018 Dec; 43():104-110. PubMed ID: 30245473
[TBL] [Abstract][Full Text] [Related]
6. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes.
Ahrén B
Nat Rev Drug Discov; 2009 May; 8(5):369-85. PubMed ID: 19365392
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Islet Transplantation for the Last 30 Years.
Farney AC; Sutherland DE; Opara EC
Pancreas; 2016 Jan; 45(1):8-20. PubMed ID: 26658037
[TBL] [Abstract][Full Text] [Related]
9. The Role of Estrogens in Pancreatic Islet Physiopathology.
Mauvais-Jarvis F; Le May C; Tiano JP; Liu S; Kilic-Berkmen G; Kim JH
Adv Exp Med Biol; 2017; 1043():385-399. PubMed ID: 29224104
[TBL] [Abstract][Full Text] [Related]
10. Effects of combining linagliptin treatment with BI-38335, a novel SGLT2 inhibitor, on pancreatic islet function and inflammation in db/db mice.
Chen L; Klein T; Leung PS
Curr Mol Med; 2012 Sep; 12(8):995-1004. PubMed ID: 22804249
[TBL] [Abstract][Full Text] [Related]
11. Insulinotropic and antidiabetic effects of 17β-estradiol and the GPR30 agonist G-1 on human pancreatic islets.
Kumar R; Balhuizen A; Amisten S; Lundquist I; Salehi A
Endocrinology; 2011 Jul; 152(7):2568-79. PubMed ID: 21521748
[TBL] [Abstract][Full Text] [Related]
12. Reduced insulin secretion function is associated with pancreatic islet redistribution of cell adhesion molecules (CAMS) in diabetic mice after prolonged high-fat diet.
Falcão VT; Maschio DA; de Fontes CC; Oliveira RB; Santos-Silva JC; Almeida AC; Vanzela EC; Cartaxo MT; Carvalho CP; Collares-Buzato CB
Histochem Cell Biol; 2016 Jul; 146(1):13-31. PubMed ID: 27020567
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological agents that directly modulate insulin secretion.
Doyle ME; Egan JM
Pharmacol Rev; 2003 Mar; 55(1):105-31. PubMed ID: 12615955
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-Like Peptide 1 Analogs and their Effects on Pancreatic Islets.
Tudurí E; López M; Diéguez C; Nadal A; Nogueiras R
Trends Endocrinol Metab; 2016 May; 27(5):304-318. PubMed ID: 27062006
[TBL] [Abstract][Full Text] [Related]
15. Effect of Conversion to CTLA4Ig on Tacrolimus-Induced Diabetic Rats.
Jin L; Lim SW; Jin J; Luo K; Ko EJ; Chung BH; Lin HL; Yang CW
Transplantation; 2018 Apr; 102(4):e137-e146. PubMed ID: 29319618
[TBL] [Abstract][Full Text] [Related]
16. Anti-diabetic effect of mulberry leaf polysaccharide by inhibiting pancreatic islet cell apoptosis and ameliorating insulin secretory capacity in diabetic rats.
Zhang Y; Ren C; Lu G; Mu Z; Cui W; Gao H; Wang Y
Int Immunopharmacol; 2014 Sep; 22(1):248-57. PubMed ID: 25023123
[TBL] [Abstract][Full Text] [Related]
17. Placental peptides regulating islet adaptation to pregnancy: clinical potential in gestational diabetes mellitus.
Simpson S; Smith L; Bowe J
Curr Opin Pharmacol; 2018 Dec; 43():59-65. PubMed ID: 30199758
[TBL] [Abstract][Full Text] [Related]
18. Proposed mechanisms for oligonucleotide IMT504 induced diabetes reversion in a mouse model of immunodependent diabetes.
Bianchi MS; Bianchi S; Hernado-Insúa A; Martinez LM; Lago N; Libertun C; Chasseing NA; Montaner AD; Lux-Lantos VA
Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E380-95. PubMed ID: 27329801
[TBL] [Abstract][Full Text] [Related]
19. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
Vague P; Vague J
Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
[No Abstract] [Full Text] [Related]
20. Beneficial effect of pretreatment of islets with fibronectin on glucose tolerance after islet transplantation.
Hamamoto Y; Fujimoto S; Inada A; Takehiro M; Nabe K; Shimono D; Kajikawa M; Fujita J; Yamada Y; Seino Y
Horm Metab Res; 2003 Aug; 35(8):460-5. PubMed ID: 12953162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]